Ascension Asset Management’s Merck MRK Stock Holding History

Ascension Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$2.66M	Sell	21,524 -225	-1%	-$29K	1.39%	21
2024 Q1	$2.87M	Buy	+21,749	New	+$2.68M	1.55%	16
2023 Q2	$2.5M	Buy	+21,649	New	+$2.46M	1.53%	18
2022 Q4	$2.43M	Hold	21,899	–	–	1.75%	16
2022 Q3	$1.89M	Hold	21,899	–	–	1.48%	19
2022 Q2	$2M	Buy	+21,899	New	+$1.94M	1.47%	22
2021 Q4	$1.67M	Sell	21,766 -200	-0.9%	-$15.9K	0.99%	39
2021 Q3	$1.65M	Hold	21,966	–	–	1.08%	39
2021 Q2	$1.71M	Sell	21,966 -1,369	-6%	-$102K	1.12%	39
2021 Q1	$1.72M	Buy	+23,335	New	+$1.72M	1.2%	35
2020 Q4	–	Sell	-10,569	Closed	-$837K	–	76
2020 Q3	$837K	Buy	+10,569	New	+$828K	0.67%	56
2020 Q1	$776K	Sell	10,569 -79	-0.7%	-$6.21K	0.81%	56
2019 Q4	$924K	Hold	10,648	–	–	0.8%	55
2019 Q3	$855K	Sell	10,648 -52	-0.5%	-$4.17K	0.79%	56
2019 Q2	$856K	Hold	10,700	–	–	0.75%	55
2019 Q1	$849K	Hold	10,700	–	–	0.76%	58
2018 Q4	$780K	Sell	10,700 -419	-4%	-$29.6K	0.79%	56
2018 Q3	$753K	Sell	11,119 -876	-7%	-$55.8K	0.66%	60
2018 Q2	$695K	Hold	11,995	–	–	0.64%	60
2018 Q1	$623K	Hold	11,995	–	–	0.57%	63
2017 Q4	$644K	Buy	+11,995	New	+$665K	0.59%	61

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ascension Asset Management's MRK Position: Q2 2024 in Review

Ascension Asset Management reduced its Merck (MRK) stake by 1% in Q2 2024, selling an estimated $29K and leaving 21,524 shares worth $2.66M. The position accounts for 1.39% of the portfolio, ranked #21.

Ascension Asset Management first reported a position in MRK in Q4 2017 and has held it in 21 quarters since. The position peaked at $2.87M in Q1 2024. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

Ascension Asset Management held 21,524 shares of Merck worth $2.66M as of Q2 2024.
Ascension Asset Management sold 225 Merck shares in Q2 2024, an estimated $29K.
Merck made up 1.39% of Ascension Asset Management's portfolio in Q2 2024, its #21 holding.
Ascension Asset Management first reported a position in Merck in Q4 2017 and has held it in 21 quarters since.
Ascension Asset Management's Merck position peaked at $2.87M in Q1 2024.
3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Ascension Asset Management's 13F filing for Q2 2024, filed 16 Aug 2024.